SERPINB9 is significantly upregulated in the C2 subtype, and previous research has demonstrated its pivotal function in enhancing tumor cell survival and promoting the existence of immune-suppressive cells within the TME (Jiang et al., 2020). Here, SERPINB9 is linked to neoplasm.